Pregn-5-en-3-ol,(3)-(9CI)
- CAS No.
- 2862-58-0
- Chemical Name:
- Pregn-5-en-3-ol,(3)-(9CI)
- Synonyms
- Δ5-Pregnen-3β-ol;Pregn-5-en-3β-ol;(3β)-Pregn-5-en-3-OL;3β-Hydroxypregn-5-ene;3beta-Hydroxypregn-5-ene;Pregn-5-en-3-ol,(3)-(9CI);(3β)-Prostaglandin-5-ene-3-ol;(3S,8S,9S,10R,13R,14S,17S)-17-ethyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
- CBNumber:
- CB1547513
- Molecular Formula:
- C21H34O
- Molecular Weight:
- 302.49406
- MDL Number:
- MOL File:
- 2862-58-0.mol
- MSDS File:
- SDS
| form | Solid |
|---|---|
| color | White to off-white |
| FDA UNII | I4Y4N2G542 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501 |
Pregn-5-en-3-ol,(3)-(9CI) price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-1141782 | Pregn-5-en-3β-ol ≥98% | 2862-58-0 | 100mg | $90 | 2026-06-04 | Buy |
| ChemScene | CS-1141782 | Pregn-5-en-3β-ol ≥98% | 2862-58-0 | 250mg | $142 | 2026-06-04 | Buy |
| ChemScene | CS-1141782 | Pregn-5-en-3β-ol ≥98% | 2862-58-0 | 1g | $286 | 2026-06-04 | Buy |
| aablocks | AA002VT8 | (3β)-Pregn-5-en-3-ol >98% | 2862-58-0 | 5mg | $63 | 2026-05-28 | Buy |
| aablocks | AA002VT8 | (3β)-Pregn-5-en-3-ol 98% | 2862-58-0 | 100mg | $72 | 2026-05-28 | Buy |
Pregn-5-en-3-ol,(3)-(9CI) Chemical Properties, Uses, Production
Uses
Pregn-5-en-3β-ol, a steroid compound, when formulated as the biscarboxylic acid hemiesters along with androst-5-en-3β-ol, serves as a potent positive allosteric modulator of NMDA (N-methyl-D-aspartate) receptors, making it applicable for research into psychiatric disorders[1].
Definition
ChEBI: 3beta-Hydroxypregn-5-ene is a corticosteroid hormone.
References
[1] Marika Matousova, et al. Pregn-5-en-3β-ol and androst-5-en-3β-ol dicarboxylic acid esters as potential therapeutics for NMDA hypofunction: In vitro safety assessment and plasma stability. Steroids. 2019 Jul:147:4-9. DOI:10.1016/j.steroids.2018.09.012
Pregn-5-en-3-ol,(3)-(9CI) Preparation Products And Raw materials
Raw materials
Preparation Products
Pregn-5-en-3-ol,(3)-(9CI) Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai TenSus Biotechnology Co., Ltd. | 021-50895067 18616507272;13681616114;15020344067 | tensus@163.com | China | 8029 | 58 |
| Shanghai Minhan Pharmaceutical Technology Co., Ltd. | 17612188245 | 2816925681@qq.com | China | 8316 | 58 |
| Zhengzhou Converging Chemical Co. LTD | 0371-53399770 18037166334 | 3857571523@qq.com | China | 7148 | 58 |
| Shanghai Yanbang Pharmaceutical Technology Co., Ltd | 15618536883 | 1228181347@qq.com | China | 7948 | 58 |
| Shanghai Haohong Scientific Co., Ltd. | 400-8210725 4008210725 | malulu@leyan.com | China | 39319 | 58 |
| Shureli Biopharma Co.,Ltd | 0871-68355600 18787766125 | 756338076@qq.com | China | 676 | 58 |
| Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd | 025-5885952 15955137747 | sales@aikonchem.com | China | 8012 | 58 |
| Shanghai Daken Advanced Materials Co.,Ltd | +86-2158073036 | info@dakenam.com | China | 14050 | 58 |
